Related Experiment Video
Updated: Aug 9, 2026

Modeling Hepatitis B Virus Infection in Non-Hepatic 293T-NE-3NRs Cells
Published on: June 5, 2020
HEV, TTV and GBV-C/HGV markers in patients with acute viral hepatitis
A C Lyra1, J R R Pinho, L K Silva
1Departamento de Gastroenterologia, Universidade de São Paulo, São Paulo, SP, Brasil. aclyra@atarde.com.br
Insights
Hepatitis E virus (HEV) co-infection was found in some acute hepatitis A cases, suggesting HEV may cause some sporadic non-A-C hepatitis. Torque teno virus (TTV) and GB virus C (GBV-C)/Hepatitis G virus (HGV) were common but not linked to acute hepatitis etiology.
Area of Science:
- Hepatology
- Virology
- Infectious Diseases
Background:
- Hepatitis viral infections pose a significant global health burden.
- The roles of Hepatitis E virus (HEV), Torque teno virus (TTV), and GB virus C (GBV-C)/Hepatitis G virus (HGV) in acute viral hepatitis require further investigation.
- Understanding co-infections and the etiology of non-A-C hepatitis is crucial for effective diagnosis and treatment.
Purpose of the Study:
- To determine the prevalence of HEV, TTV, and GBV-C/HGV in patients with acute viral hepatitis A, B, and non-A-C.
- To investigate the potential role of these viruses in the etiology of acute hepatitis.
- To identify genotypes of TTV and GBV-C/HGV circulating in the studied population.
Main Methods:
- Sera from 94 patients with acute hepatitis A, B, or non-A-C, and 71 blood donors were analyzed.
- HEV antibodies (IgM and IgG) were detected using enzyme immunoassay.
- TTV and GBV-C/HGV were detected and genotyped using nested PCR, sequencing, and phylogenetic analysis.
Main Results:
- Anti-HEV IgG was detected in 38% of hepatitis A, 10% of hepatitis B, and 17% of non-A-C cases.
- Anti-HEV IgM was found in 4 hepatitis A patients and 1 non-A-C hepatitis patient, suggesting co-infection or HEV etiology.
- TTV and GBV-C/HGV were detected in 21% and 9% of hepatitis patients, respectively, and in 31% and 10% of donors; their presence was associated with lower aminotransferase levels and not linked to acute hepatitis etiology.
Conclusions:
- Hepatitis E virus (HEV) co-infection may occur in acute hepatitis A cases and could be responsible for some sporadic non-A-C hepatitis cases in Salvador, Brazil.
- TTV genotypes 1-4 and GBV-C/HGV genotypes 1-2 are prevalent in the studied population.
- TTV and GBV-C/HGV infections do not appear to play a significant role in the etiology of acute hepatitis.
Abstract:
The aim of the present study was to evaluate the prevalence of HEV, TTV and GBV-C/GBV-C/HGV in patients with acute viral hepatitis A, B and non-A-C. We evaluated sera of 94 patients from a sentinel program who had acute hepatitis A (N = 40), B (N = 42) and non-A-C (N = 12); 71 blood donors served as controls. IgM and anti-HEV IgG antibodies were detected by enzyme immunoassay using commercial kits. TTV and GBV-C/HGV were detected by nested PCR; genotyping was done by sequencing and phylogenetic analysis. Anti-HEV IgG was present in 38, 10 and 17% of patients with hepatitis A, B and non-A-C. Four patients with hepatitis A and 1 with non-A-C hepatitis also had anti-HEV IgM detected in serum. TTV was detected in 21% of patients with acute hepatitis and in 31% of donors. GBV-C/HGV was detected in 9% of patients with hepatitis, and in 10% of donors. We found TTV isolates of genotypes 1, 2, 3, and 4 and GBV-C/HGV isolates of genotypes 1 and 2. Mean aminotransferase levels were lower in patients who were TTV or GBV-C/HGV positive. In conclusion, the detection of anti-HEV IgM in some acute hepatitis A cases suggests co-infection with HEV and hepatitis E could be the etiology of a few cases of sporadic non-A-C hepatitis in Salvador, Brazil. TTV genotype 1, 2, 3 and 4 isolates and GBV-C/HGV genotype 1 and 2 strains are frequent in the studied population. TTV and GBV-C/HGV infection does not appear to have a role in the etiology of acute hepatitis.
More Related Videos
11:34A Competent Hepatocyte Model Examining Hepatitis B Virus Entry through Sodium Taurocholate Cotransporting Polypeptide as a Therapeutic Target
Published on: May 10, 2022
04:11Real-Time Polymerase Chain Reaction-Based Detection and Quantification of Hepatitis B Virus DNA
Published on: December 15, 2023
Related Concept Videos
Cytomegalovirus Disease
Hepatitis
Viral Hepatitis I: Introduction